Literature DB >> 338510

Proteolysis of bovine immunoglobulins.

O de Rham, H Isliker.   

Abstract

Bovine serum IgG1, colostral IgG1 and serum IgG2 with anti-ferritin activity were digested with pepsin or trypsin. Their fragments were characterized by immunoelectrophoresis, gel electrophoresis and gel filtration; their ferritin-binding ability was determined. The kinetics of proteolysis were established by measuring the appearance of free amino groups. No differences were observed between serum and colostrum IgG1. IgG1 was more susceptible to pepsin, and IgG2 to trypsin. This became evident from both the amount of intact IgG determined by gel electrophoresis, immunoelectrophoresis or gel filtration, and from the kinetics of the appearance of amino groups. A model is presented to explain the size, mobilities and properties of the obtained fragments.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 338510     DOI: 10.1159/000231910

Source DB:  PubMed          Journal:  Int Arch Allergy Appl Immunol        ISSN: 0020-5915


  10 in total

1.  Structural features of bovine colostral immunoglobulin that confer proteolytic stability in a simulated intestinal fluid.

Authors:  Randall E Burton; Skaison Kim; Rutvij Patel; Deborah S Hartman; Daniel E Tracey; Barbara S Fox
Journal:  J Biol Chem       Date:  2020-07-14       Impact factor: 5.157

2.  Oral ingestion of egg yolk immunoglobulin from hens immunized with an enterotoxigenic Escherichia coli strain prevents diarrhea in rabbits challenged with the same strain.

Authors:  C O'Farrelly; D Branton; C A Wanke
Journal:  Infect Immun       Date:  1992-07       Impact factor: 3.441

3.  Oral administration of immunoglobulin G-enhanced colostrum alleviates insulin resistance and liver injury and is associated with alterations in natural killer T cells.

Authors:  T Adar; A Ben Ya'acov; G Lalazar; Y Lichtenstein; D Nahman; M Mizrahi; V Wong; B Muller; G Rawlin; Y Ilan
Journal:  Clin Exp Immunol       Date:  2012-02       Impact factor: 4.330

4.  Survival of anti-Clostridium difficile bovine immunoglobulin concentrate in the human gastrointestinal tract.

Authors:  C P Kelly; S Chetham; S Keates; E F Bostwick; A M Roush; I Castagliuolo; J T LaMont; C Pothoulakis
Journal:  Antimicrob Agents Chemother       Date:  1997-02       Impact factor: 5.191

Review 5.  Oral delivery of antibodies. Future pharmacokinetic trends.

Authors:  R M Reilly; R Domingo; J Sandhu
Journal:  Clin Pharmacokinet       Date:  1997-04       Impact factor: 6.447

6.  Resistance of bovine colostral anti-cholera toxin antibody to in vitro and in vivo proteolysis.

Authors:  R E McClead; S A Gregory
Journal:  Infect Immun       Date:  1984-05       Impact factor: 3.441

7.  Treatment of diarrhoea in human immunodeficiency virus-infected patients with immunoglobulins from bovine colostrum.

Authors:  J A Rump; R Arndt; A Arnold; C Bendick; H Dichtelmüller; M Franke; E B Helm; H Jäger; B Kampmann; P Kolb
Journal:  Clin Investig       Date:  1992-07

8.  Treatment of infantile E. coli gastroenteritis with specific bovine anti-E. coli milk immunoglobulins.

Authors:  C Mietens; H Keinhorst; H Hilpert; H Gerber; H Amster; J J Pahud
Journal:  Eur J Pediatr       Date:  1979       Impact factor: 3.183

Review 9.  Perspectives on immunoglobulins in colostrum and milk.

Authors:  Walter L Hurley; Peter K Theil
Journal:  Nutrients       Date:  2011-04-14       Impact factor: 5.717

Review 10.  Survival and digestibility of orally-administered immunoglobulin preparations containing IgG through the gastrointestinal tract in humans.

Authors:  Victoria S Jasion; Bruce P Burnett
Journal:  Nutr J       Date:  2015-03-07       Impact factor: 3.271

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.